As a result, BPC-157 ARG remains an interesting option for audiences following research on tissue integrity, digestive tract and regenerative processes at the research level
Perez explains that pharmaceutical companies would be clambering to fund and produce them
Mar 2009;64(3):340-50
Lai XJ, Zhang L, Li JS, et al
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 145:1726 Sun M, Zhai X, Xue K, Hu L, Yang X, Li G, Si L (2011) Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: linear correlation with oral bioavailabilities in rats
From a WADA perspective, BPC-157 has been listed under Section S0 Non-Approved Substances on the Prohibited List since 2022 [15]